CTLA4 and neoplasm: Tumor-infiltrating immune cell levels, the expressions of immune checkpoints including PD-1, PD-L1 and CTLA-4, and TMB were found to be elevated in the high-risk group relative to the low-risk group, as classified by the genomic model-derived from DUSP5.